Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Gene Therapy|July 15, 2020
Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineeringFrancesco Piras, Anna Kajaste-Rudnitski
The Journal of Experimental Medicine|December 6, 2024
Antiviral immunity lassoed down by excess RNAErika Valeri, Anna Kajaste-Rudnitski
Human Gene Therapy|March 27, 2015
Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cellsAnna Kajaste-Rudnitski, Luigi Naldini
Blood|January 12, 2012
HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte linesSamanta A Mariani, Immacolata Brigida, Anna Kajaste-Rudnitski, et al.
Stem Cell Reports|March 24, 2017
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene TherapyErika Zonari, Giacomo Desantis, Carolina Petrillo, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 7, 2013
Lipid-based nanoparticles as nonviral gene delivery vectorsDaniele Pezzoli, Anna Kajaste-Rudnitski, Roberto Chiesa, et al.
Cell Stem Cell|May 5, 2023
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapySamuele Ferrari, Erika Valeri, Anastasia Conti, et al.
STAR Protocols|March 7, 2023
Protocol to differentiate monolayer human induced pluripotent stem cells into inflammatory responsive astrocytesAnna Maria Sole Giordano, Monah Abou Alezz, Ivan Merelli, et al.
Amino Acids|November 28, 2009
Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22Anna Kajaste-Rudnitski, Cinzia Pultrone, Flavia Marzetta, et al.
The Journal of Biological Chemistry|December 24, 2005
The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cellsAnna Kajaste-Rudnitski, Tomoji Mashimo, Marie-Pascale Frenkiel, et al.
Pageof 27